查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
紅生物科技市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1140657

紅生物科技市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Red Biotechnology Market (Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, and Genetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 176 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球紅生物科技市場相關調查，提供市場概要，以及2022年～2031年的預測，各用途，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球紅生物科技市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球紅生物科技市場分析與預測，2017年～2031年

第5章 主要洞察

第6章 全球紅生物科技市場分析與預測，各用途

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測，各用途，2017年～2031年
    • 生物醫藥品製造
    • 藥物基因體學
    • 基因治療
    • 遺傳基因檢驗
  • 各用途的市場魅力分析

第7章 全球紅生物科技市場分析與預測，各終端用戶

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測，各終端用戶，2017年～2031年
    • 生物醫藥品產業
    • CMO·CRO
    • 調查
    • 其他
  • 各終端用戶的市場魅力分析

第8章 全球紅生物科技市場分析與預測，各地區

  • 主要調查結果
  • 市場價值預測，各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 各地區的市場魅力分析

第9章 北美的紅生物科技市場分析與預測

第10章 歐洲的紅生物科技市場分析與預測

第11章 亞太地區的紅生物科技市場分析與預測

第12章 南美的紅生物科技市場分析與預測

第13章 中東·非洲的紅生物科技市場分析與預測

第14章 競爭情形

  • 市場參與企業 - 競爭矩陣(等級及各企業規模)
  • 市場佔有率分析，各企業，2021年
  • 企業簡介
    • Pfizer, Inc.
    • Biogen, Inc.
    • Amgen, Inc.
    • AstraZeneca plc
    • Gilead Sciences, Inc.
    • Celgene Corporation(Bristol-Myers Squibb Company)
    • F. Hoffmann-La Roche, Ltd.
    • Merck KGaA
    • Regeneron Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company Limited
Product Code: TMRGL2063

The report provides revenue of the global red biotechnology market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global red biotechnology market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the red biotechnology market.

The report delves into the competitive landscape of the global red biotechnology market. Key players operating in the global red biotechnology market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global red biotechnology market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Red Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Red Biotechnology Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Reimbursement Scenario by Region/globally
  • 5.3. Key Industry Events (merger & acquisitions)
  • 5.4. Covid-19 Impact Analysis

6. Global Red Biotechnology Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Application, 2017-2031
    • 6.3.1. Biopharmaceutical Production
    • 6.3.2. Pharmacogenomics
    • 6.3.3. Gene Therapy
    • 6.3.4. Genetic Testing
  • 6.4. Market Attractiveness Analysis, by Application

7. Global Red Biotechnology Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Biopharmaceutical Industry
    • 7.3.2. CMO & CRO
    • 7.3.3. Research Institutes
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Red Biotechnology Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Red Biotechnology Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Application, 2017-2031
    • 9.2.1. Biopharmaceutical Production
    • 9.2.2. Pharmacogenomics
    • 9.2.3. Gene Therapy
    • 9.2.4. Genetic Testing
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Biopharmaceutical Industry
    • 9.3.2. CMO & CRO
    • 9.3.3. Research Institutes
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Red Biotechnology Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Application, 2017-2031
    • 10.2.1. Biopharmaceutical Production
    • 10.2.2. Pharmacogenomics
    • 10.2.3. Gene Therapy
    • 10.2.4. Genetic Testing
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Biopharmaceutical Industry
    • 10.3.2. CMO & CRO
    • 10.3.3. Research Institutes
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Red Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Application, 2017-2031
    • 11.2.1. Biopharmaceutical Production
    • 11.2.2. Pharmacogenomics
    • 11.2.3. Gene Therapy
    • 11.2.4. Genetic Testing
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Biopharmaceutical Industry
    • 11.3.2. CMO & CRO
    • 11.3.3. Research Institutes
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Red Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Application, 2017-2031
    • 12.2.1. Biopharmaceutical Production
    • 12.2.2. Pharmacogenomics
    • 12.2.3. Gene Therapy
    • 12.2.4. Genetic Testing
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Biopharmaceutical Industry
    • 12.3.2. CMO & CRO
    • 12.3.3. Research Institutes
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Red Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Application, 2017-2031
    • 13.2.1. Biopharmaceutical Production
    • 13.2.2. Pharmacogenomics
    • 13.2.3. Gene Therapy
    • 13.2.4. Genetic Testing
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Biopharmaceutical Industry
    • 13.3.2. CMO & CRO
    • 13.3.3. Research Institutes
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Pfizer, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. Biogen, Inc.
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Amgen, Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. AstraZeneca plc
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Gilead Sciences, Inc.
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Celgene Corporation (Bristol-Myers Squibb Company)
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. F. Hoffmann-La Roche, Ltd.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Merck KGaA
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Regeneron Pharmaceuticals, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. Takeda Pharmaceutical Company Limited
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments

List of Tables

  • Table 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 02: Global Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 03: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Region, 2022-2031
  • Table 04: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2022-2031
  • Table 05: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 06: North America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 07: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 08: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 09: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 10: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 11: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 12: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 13: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 14: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 15: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031
  • Table 16: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2022-2031
  • Table 17: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2022-2031
  • Table 18: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2022-2031

List of Figures

  • Figure 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, 2022-2031
  • Figure 02: Global Red Biotechnology Market Value Share (%), by Application, 2021
  • Figure 03: Global Red Biotechnology Market Value Share (%), by End-user, 2021
  • Figure 04: Global Red Biotechnology Market Value Share (%), by Region, 2021
  • Figure 05: Global Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 06: Global Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 07: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Production, 2022-2031
  • Figure 08: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Gene Therapy, 2022-2031
  • Figure 09: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Pharmacogenomics, 2022-2031
  • Figure 10: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Genetic Testing, 2022-2031
  • Figure 11: Global Red Biotechnology Market Value Share Analysis, by End-user, 2021-2031
  • Figure 12: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Industry, 2022-2031
  • Figure 13: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by CMO & CRO, 2022-2031
  • Figure 14: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Research Institutes, 2022-2031
  • Figure 15: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Others, 2022-2031
  • Figure 16: Global Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 17: Global Red Biotechnology Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 18: Global Red Biotechnology Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 19: North America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 20: North America Red Biotechnology Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America Red Biotechnology Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 22: North America Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 23: North America Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 24: North America Red Biotechnology Market Value Share Analysis, by End-user, 2021-2031
  • Figure 25: North America Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 26: Europe Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 27: Europe Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 28: Europe Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 29: Europe Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 30: Europe Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 31: Europe Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 32: Europe Red Biotechnology Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 33: Asia Pacific Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 34: Asia Pacific Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 35: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 36: Asia Pacific Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 37: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 38: Asia Pacific Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 39: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 40: Latin America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 41: Latin America Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Latin America Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 43: Latin America Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 44: Latin America Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 45: Latin America Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 46: Latin America Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 47: Middle East & Africa Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2022-2031
  • Figure 48: Middle East & Africa Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 49: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 50: Middle East & Africa Red Biotechnology Market Value Share (%), by Application, 2021 and 2031
  • Figure 51: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 52: Middle East & Africa Red Biotechnology Market Value Share Analysis, by End-user, 2022-2031
  • Figure 53: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 54: Global Red Biotechnology Market Share, by Company, 2021